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CASE PRESENTATION
A 19-year-old gravid Hispanic female (G2P1) at an
unknown gestational age presented to the Emergency
Room (ER) with new onset of gross hematuria and a
2-week history of swelling and tenderness of the nose and
upper lip. She was prescribed a 10-day course of
azithromycin for presumed cellulitis. After 10 days, she
returned to the ER with worsening nasal swelling and
complaints of lightheadedness. She denied fevers, chills,
night sweats, hemoptysis, dysuria, shortness of breath,
cough, oral ulcers, dysphagia, or rashes. The patient had
moved to the US from Mexico 6 months prior to
admission. Her only significant past medical history was
chronic upper airway irritation for 2 years. There was no
family history of renal disease.
Her temperature was 100.11F, with a regular pulse of
110 beats/min, and respirations of 15/min. Blood pressure
was 104/66 while seated. The nasal alae were edematous
with erythema extending to the philtrum (Figure 1a). The
nasal septum was necrotic with an anterior perforation
and purulent discharge. The sclerae were anicteric and no
oral erythema or ulceration was seen. There was no
lymphadenopathy. Cardiovascular examination revealed a
regular tachycardic rhythm with normal heart sounds and
a grade III/VI systolic ejection murmur. Neurologic,
pulmonary, and abdominal examinations were
unremarkable. The extremities revealed normal pulses
without edema or clubbing.
Laboratory values on presentation were as follows:
hemoglobin, 6.1 g/dl (61 g/l) (normal range, 13–18 g/dl
(130–180 g/l)); white-cell count, 5.5 109/l (normal range
4.3–10.8 109/l) with a normal differential; platelet count,
348 109/l (normal range, 150–500 109/l); BUN, 18 mg/dl
(6.4 mmol/l) (normal range, 10–30 mg/dl (3.6–10.7 mmol/l));
serum creatinine, 1.7 mg/dl (150mmol/l); serum protein,
5.8 g/dl (58 g/l) (normal range, 6.3–8.2 g/dl (63–82 g/l)); serum
albumin, 2.7 mg/dl (normal range, 3.5–4.9 g/dl (35–49 g/l)).
The creatinine clearance was 28 ml/min. Serum sodium,
potassium, chloride, calcium, bicarbonate,
glucose, transaminases, and alkaline phosphatase were
normal. Urinalysis showed 3þ protein and 4þ blood.
Microscopic examination of the urine showed many RBCs
per high power field (too numerous to count), multiple red
blood cell casts, waxy casts, epithelial casts, and hyaline
casts. The 24-h urine protein was 3984 mg. The following
serologies were negative or normal: anti-neutrophil cyto-
plasmic antibody, anti-nuclear antibody, anti-double
stranded DNA antibody, hepatitis B surface antigen,
hepatitis C antibody, human immunodeficiency virus
antibody, anti-glomerular basement membrane antibody,
antistreptolysin-O, and serum complements. The erythrocyte
sedimentation rate was greater than 140 mm/h.
Computer tomography of the sinuses disclosed ex-
tensive bilateral nasal soft tissue swelling extending to the
medial premaxillary region associated with a small
perforation of the nasal septum and local hemorrhage.
Chest radiograph was unremarkable. The ultrasound of
the abdomen was consistent with a pregnancy of 9 weeks
and 5 days. Renal ultrasound showed normal-sized
kidneys with normal echogenicity.
The patient was hospitalized for blood transfusions and
supportive care. She was treated empirically with nafcillin
for nasal cellulitis. A renal biopsy and endoscopic nasal
biopsy were performed. Although anti-neutrophil
cytoplasmic antibody serologies were negative, the
possibility of Wegener’s granulomatosis was strongly
entertained based on the presentation with a destructive
nasal lesion, hematuria, and acute renal failure.
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NASAL BIOPSY FINDINGS
The endoscopic nasal biopsy showed a dense infiltrate
composed of irregular medium-sized to large atypical
lymphoid cells exhibiting a high mitotic index admixed with
smaller lymphocytes (Figure 1b). Focally, there were areas of
necrosis and vascular invasion. By immunohistochemistry,
the majority of the atypical lymphoid cells were CD2þ ,
CD3þ (cytoplasmic), CD5, CD7, and both CD4 and
CD8. The atypical cells also expressed CD56 (neural cell
adhesion molecule), a marker of natural killer (NK) cells).
Scattered mature CD4þ or CD8þ lymphocytes were also
present. CD20 showed few B cells and CD21 revealed no
evidence of follicle formation. In situ hybridization per-
formed on paraffin-embedded tissue sections revealed
positive staining of most cells with an oligonucleotide probe
specific for Epstein–Barr virus encoded RNA. The morpho-
logical features in combination with immunophenotype were
consistent with extranodal NK/T-cell lymphoma, nasal type
(previously referred to as ‘lethal midline granuloma’).
KIDNEY BIOPSY FINDINGS
The kidney biopsy contained 13 glomeruli for light micro-
scopy, none of which were globally sclerotic. Glomeruli
displayed moderate diffuse and global increase in mesangial
cell number and matrix associated with mesangial expansion
by glassy eosinophilic, fuchsinophilic deposits (Figure 1c).
Superimposed on these mesangial proliferative features, 10
glomeruli displayed segmental endocapillary proliferation
with focal infiltrating mononuclear leukocytes and rare
duplication of glomerular basement membrane. In three of
these glomeruli, the endocapillary proliferative lesions
exhibited necrotizing features. Ten (77%) glomeruli con-
tained segmental to circumferential crescents that ranged in
age from cellular to fibrocellular (Figure 1c). There was mild
Figure 1 | Pathologic findings. (a) There is swelling and erythema of the nose extending to the upper lip. The external nasal septum appears
ulcerated with purulent exudate. (b) The nasal biopsy (performed on the left nares) reveals an atypical dense infiltrate of medium-sized
lymphoid cells admixed with a few smaller cells (H&E, original magnification  400). (c) A representative glomerulus shows compression of the
tuft by a large cellular crescent admixed with fibrin. In the distorted tuft, there is global mesangial and segmental endocapillary hypercellularity.
(H&E, original magnification  400). (d) Immunofluorescence staining shows intense positivity for IgA in a global mesangial distribution
(original magnification  400).
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focal tubular atrophy and interstitial fibrosis involving
approximately 10% of the cortex. Approximately 80% of
the cortex had interstitial expansion by edema and moderate
diffuse polymorphic inflammatory infiltrates of small mature
lymphocytes, monocytes, scattered plasma cells, and neu-
trophils. There were abundant red blood cell casts associated
with tubular degenerative and regenerative changes. Arteries
and arterioles were unremarkable. No arteritis was identified.
In situ hybridization performed on a paraffin-embedded
renal biopsy section with an oligonucleotide probe specific
for Epstein–Barr virus-encoded RNA was negative.
Three glomeruli were studied by immunofluorescence and
showed 2–3þ granular global mesangial and segmental
glomerular capillary wall staining for IgA (Figure 1d) and C3,
with trace IgG, 1þ IgM, negative C1q, 1þ kappa, and
2–3þ lambda.
By electron microscopy, the mesangial areas were globally
expanded by moderate increase in mesangial cell number and
matrix containing numerous small to medium-sized mesan-
gial electron dense deposits. There was segmental endocapil-
lary proliferation associated with segmental subendothelial
extension of small electron dense deposits. No endothelial
tubuloreticular inclusions were seen. The glomerular tufts
were focally compressed by cellular crescents. There was
moderate effacement of foot processes involving approxi-
mately 60% of the glomerular capillary surface area. No
tubulointerstitial electron dense deposits were identified.
FINAL DIAGNOSIS
Diffuse endocapillary and extracapillary proliferative glome-
rulonephritis, severe, consistent with IgA nephropathy
(associated with NK/T-cell lymphoma, nasal type).
CLINICAL FOLLOW-UP
Following the results of nasal and renal biopsy, the patient
underwent elective termination of pregnancy and was started
on high-dose chemotherapy with cycles of cyclophospha-
mide, doxorubicin, vincristine, and prednisolone (CHOP)
every 3 weeks. The patient’s creatinine returned to her
presumed baseline of 0.7 mg/dl (62 mmol/l), however the
hematuria and proteinuria persisted. At 3 months after
starting chemotherapy, she developed sepsis and died; no
autopsy was performed.
DISCUSSION
IgA nephropathy (IgAN) is the most common cause of
glomerulonephritis worldwide. Patients typically present
either with periodic macrohematuria (40–50%) or persistent
microhematuria (30–40%), associated with proteinuria and,
in many cases, renal insufficiency.1–2 There is often a history
of antecedent respiratory tract infection. Although most cases
of IgAN are idiopathic, identification of secondary IgAN
(such as because of cirrhosis, inflammatory bowel disease, or
malignancy) serves more than an academic purpose, as
treatment strategies and prognosis differ depending on the
underlying cause.
Pathomechanisms implicated in primary and secondary
IgAN can be classified into three non-mutually exclusive
categories: defects in IgA clearance, overproduction of IgA,
and derangements in mucosal immunity. IgA exists in two
subclasses: IgA1, produced by plasma cells in the GI tract,
respiratory tract, bone marrow, lymph nodes, and spleen; and
IgA2, produced by plasma cells only in the GI and respiratory
tracts. Evidence suggests that the IgA deposits in the
glomeruli of patients with IgAN are exclusively polymeric
IgA1.3 Studies have shown that abnormal galactosylation of
IgA1 predisposes to mesangial deposition,4 and this under-
galactosylation may be due to a decrease in leukocyte b-1,3-
galactosyltransferase activity.5 The undergalactyosylated
hinge region of IgA1 may generate antigenic determinants
that are recognized by naturally occurring IgG and IgA
antibodies, leading to the production of circulating immune
complexes containing IgG and IgA1.6
Defective clearance is thought to be the dominant cause of
IgAN in hepatic disease, and up to one-third of cirrhotics will
have glomerular deposition of IgA, with or without clinical
evidence of renal disease.7 The hepatic asialoglycoprotein
receptor is the principal site of IgA catabolism, suggesting
that loss of this receptor through hepatocyte depletion may
be directly responsible for the decreased clearance.8 In
addition, it has been postulated that the hepatic asialoglyco-
protein receptor may not clear undergalactosylated IgA1 as
effectively as intact IgA1.9
Much like decreased clearance, overproduction of IgA can
promote IgAN. Up to 50% of patients with IgAN have
elevated serum IgA levels.2 Of note, overproduction of IgA is
common in human immunodeficiency virus infection and
8% of human immunodeficiency virus infected individuals
will have mesangial deposition of IgA on autopsy.10,11
Overproduction of IgA may not be sufficient to cause IgAN,
however, as exemplified by the rarity of IgA nephropathy
secondary to IgA-producing multiple myeloma. In one case
report of IgAN in the setting of IgA-producing multiple
myeloma, the IgA isolated was abnormally glycosylated, again
underscoring the importance of this biochemical modifica-
tion in the pathogenesis of IgAN.12
Alterations in mucosal immunity that promote increased
synthesis of IgA have often been implicated in the develop-
ment of IgAN. This mechanism is supported by the frequent
temporal association of antecedent respiratory and GI tract
infections with episodes of hematuria in IgAN or its systemic
variant, Henoch–Schonlein purpura. Secondary IgAN is seen
in patients with celiac disease, ulcerative colitis, Crohn’s
disease, and cystic fibrosis, among other chronic diseases
affecting the gastrointestinal and respiratory mucosa.1
IgAN has rarely been associated with lymphoma. Only
eight cases have been reported in the English literature,
including three with Hodgkin’s disease, one with mucosa-
associated lymphoid tissue (MALT) lymphoma (a low grade
B-cell non-Hodgkin’s lymphoma), and four with mycosis
fungoides (a cutaneous form of non-Hodgkin’s T-cell
lymphoma) (Table 1).13–19 The eight cases included six males
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and two females, with a mean age of 55 years (range, 29–70).
All eight patients presented with hematuria, including gross
hematuria in one. Proteinuria was documented in six
patients and full nephrotic syndrome in one. Six patients
had renal failure. On light microscopic examination of the
renal biopsy, mesangial hypercellularity was present in seven
cases, focal endocapillary hypercellularity in two, and
crescent formation in six (diffuse in two and focal in four).
Renal infiltration by lymphoma was found on biopsy only in
the case of mucosa-associated lymphoid tissue lymphoma,
together with tonsillar and gastrointestinal involvement.15
Importantly, complete renal recovery was achieved in four of
the five patients with available follow-up following treatment
with chemotherapy, with or without radiotherapy or steroid
treatment, including all three cases associated with Hodgkin’s
disease and the one case associated with mucosa-associated
lymphoid tissue lymphoma.15–18 In one case associated with
mycosis fungoides, hematuria persisted and the patient
subsequently died of lymphomatous visceral involvement
and infectious complications.14
This is the first report of IgAN occurring in association
with extranodal NK/T-cell lymphoma, nasal type. NK/T-cell
lymphoma, nasal type, is a unique type of non-Hodgkin’s
lymphoma highly associated with Epstein–Barr virus infec-
tion.20 Archaic synonyms include angiocentric lymphoma
and lethal midline granuloma. It is rare in Western
populations and much more common in Asia and Central
and South America.21–22 Clinical features include obstructive
and destructive lesions primarily of the nasal region and
sinuses, although other extranodal sites have been reported.
Histologically, the lymphomatous infiltrate often displays a
diffuse pattern, but angiocentricity with vascular invasion
and necrosis are common. The infiltrate is usually composed
of medium-sized to large cells with the following character-
istic immunophenotype: CD2þ , CD56þ , surface CD3,
cytoplasmic CD3þ , Epstein–Barr virus þ , and T-cell
receptor.20 Most cases are of NK-cell origin, although rare
cases derive from T cells, hence the designation extranodal
NK/T (instead of NK)-cell lymphoma, nasal type. The
prognosis of extranodal NK/T-cell lymphoma, nasal type is
poor. The median survival was 11 months with combined
chemotherapy and radiotherapy in a large retrospective study
from Hong Kong.23 A higher disease stage with multiorgan
involvement (such as nodal, cutaneous, pulmonary, and
hepatosplenic) and B symptoms (fever, sweats, or weight
loss) are associated with decreased survival.21
Table 1 | Main features of nine reported cases of IgAN associated with lymphoma
Case Age/sex Type of lymphoma
Clinical renal
manifestations Glomerular pattern Therapy
Length of
follow-up Renal outcome Reference
1 70/male CTCL Hematuria, renal
failure
Mesangial
proliferative GN
NP NP NP Ramirez
et al.13
2 56/male CTCL Hematuria, renal
failure
Mesangial
proliferative GN
NP NP NP Ramirez
et al.13
3 66/female CTCL Hematuria,
proteinuria
Diffuse mesangial
and focal
enodocapillary
proliferative and
crescentic GN
NP NP Persistent
hematuria (died
of lymphoma
complications)
Moe et al.14
4 62/male MALT lymphoma Gross hematuria,
proteinuria, renal
failure
Diffuse mesangial
proliferative and
crescentic GN
Chlorambucil 41 year CR (normal
urinalysis and
renal function)
Mak et al.15
5 29/male Hodgkin’s disease Hematuria,
proteinuria
Focal proliferative
and crescentic GN
Combination
chemotherapy,
radiotherapy
2 years CR Blanco et al.16
6 44/male Hodgkin’s disease Nephrotic
syndrome,
hypertension,
renal failure,
hematuria
Diffuse crescentic
GN
Combination
chemotherapy,
steroids
6 months CR Cherubini
et al.17
7 60/female Hodgkin’s disease Hematuria,
proteinuria,
renal failure
Diffuse mesangial
proliferative and
focal crescentic GN
Combination
chemotherapy,
steroids
41 year CR (normal
urinalysis and
renal function)
Bergmann
et al.18
8 54/male CTCL Hematuria,
proteinuria,
renal failure
Focal mesangial
proliferative and
crescentic GN
PUVA, etretinate,
topical steroids
NP NP Sato et al.19
9 19/female Extranodal NK/T-cell
lymphoma, nasal
type
Gross hematuria,
proteinuria,
renal failure
Diffuse proliferative
and crescentic GN
Combination
chemotherapy
3 months Persistent
hematuria and
proteinuria,
normal serum
creatinine (died
of sepsis)
Current
report
CR, complete recovery; CTCL, cutaneous T-cell lymphoma; GN, glomerulonephritis; MALT, mucosa-associated lymphoid tissue; NP, data not provided; PUVA, psoralen plus
ultraviolet A irradiation.
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The pathogenesis of IgAN associated with lymphoma is
unclear. A study of 254 patients with cutaneous T-cell
lymphoma demonstrated that 24.8% had elevated IgA levels,
suggesting a role for overproduction of IgA.24 In addition,
cutaneous T-cell lymphoma , by compromising the integu-
ment, may cause derangements in local immunity.
In our case, the close temporal relationship between
the development of NK/T-cell lymphoma, nasal type and the
clinical onset of IgA nephropathy, as well as the improvement
in renal function following chemotherapy, support that the
two conditions are pathogenetically related. Nasal mucosal
necrosis and ulceration because of lymphoma may
have stimulated hyperactivity of the local mucosal immune
system. The spectrum of lymphoma associated with IgA
nephropathy should be expanded to include NK/T-cell
lymphoma, nasal type.
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